Abstract: The present invention relates to Haemophilus parasuis polynucleotides produced by recombinant technology. It also relates to polypeptides that are expressed by said polynucleotides and also to a vaccine against H. parasuis that comprises said polypeptides. In another aspect, the invention also relates to the use of polynucleotides to determine if a strain of H. parasuis is virulent or avirulent.
Type:
Grant
Filed:
September 15, 2006
Date of Patent:
January 8, 2013
Assignee:
Fundacio Centre de Recerca en Sanitat Animal
Inventors:
Albert Bensaid, Sonia Pina Pedrero, Raquel Rivas Adan, Simone Oliveira, Enric Espuña Maso, Carmen Herrero Molina